Product
[11C]acetate
1 clinical trial
2 indications
Indication
LymphangioleiomyomatosisIndication
Tuberous Sclerosis ComplexClinical trial
Feasibility Study of [11C]Acetate Positron Emission Tomography (PET) as an Indicator of Early Response to Rapamycin in Lymphangioleiomyomatosis (LAM) PatientsStatus: Recruiting, Estimated PCD: 2023-08-30